The U.S. Food and Drug Administration has approved an antibody, nirsevimab, which would protect newborns from R.S.V., respiratory syncytial virus....
antibody
Regeneron announced that their antibody drug cocktail cuts the risk of getting Covid-19 by 82%. This would be another option...
